{"slideshow_credits": null, "snippet": "A combined company would have big businesses in specialty pharmaceuticals, generic drugs, over-the-counter treatments and nutritional products.", "abstract": "Mylan, maker of generic drugs, makes public unsolicited acquisition offer to Perrigo of about $29 billion; deal, if completed, will be latest large merger in industry that has seen number of consolidations, and proposal underscores lingering impact of many so-called inversions that took place in 2014.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES", "contributor": "Katie Thomas contributed reporting."}, "web_url": "http://www.nytimes.com/2015/04/09/business/dealbook/mylan-offers-to-acquire-perrigo-for-29-billion.html", "lead_paragraph": "A combined company would have big businesses in specialty pharmaceuticals, generic drugs, over-the-counter treatments and nutritional products.", "headline": {"main": "Mylan Offers to Acquire Perrigo for $29 Billion", "print_headline": "To Expand Its Offerings, Mylan Makes Bid to Buy a Rival Drug Maker"}, "_id": "5525510638f0d8148de1fb91", "word_count": "985", "multimedia": [{"height": 126, "url": "images/2015/04/09/business/09DBDRUG/09DBDRUG-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/04/09/business/09DBDRUG/09DBDRUG-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 392, "url": "images/2015/04/09/business/09DBDRUG/09DBDRUG-articleLarge.jpg", "legacy": {"xlarge": "images/2015/04/09/business/09DBDRUG/09DBDRUG-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "392"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/04/09/business/09DBDRUG/09DBDRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/04/09/business/09DBDRUG/09DBDRUG-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-04-09T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Mylan Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Perrigo Company", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}